A trial to extend the lifespan of pet dogs has shown promise – with marked improvement in heart health. Anti-rejection medicine rapamycin was given to dogs in phase one trials by evolutionary geneticists at the University of Washington, the Daily Telegraph reports. It is usually given to humans who’ve had a kidney transplant, but was found to extend the life …